This is an experimental animal model that mimics human non-alcoholic steatohepatitis (NASH). In this model, we used a 12% cholesterol diet together with a choline mixture to be induced in rats for 16 consecutive weeks. Liver enzymes were increased, indicating liver injury. Liver histology stainings and grading further proven evidence of NASH
Non-alcoholic steatohepatitis (NASH) is a major cause of chronic liver disease. However, most availa...
Abstract: Research in nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatit...
Research in nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH),...
Aim: The aims of this study are to establish NASH animal model utilizing 1% and 12% cholesterol diet...
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, which occurs in the ...
In 1980, Ludwig and colleagues described a series of patients with liver histology characterized by ...
BACKGROUND: Animal models are an essential tool in non-alcoholic steatohepatitis (NASH) studies. Id...
International audienceNonalcoholic fatty liver disease (NAFLD) is the most common chronic liver dise...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Nonalcoholic steatohepatitis (NASH) arises from a variable interplay between environmental factors a...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Non-alcoholic steatohepatitis (NASH) develops from non-alcoholic fatty liver disease (NAFLD). Curren...
Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver d...
Research in nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH),...
A condition defined as nonalcoholic fatty liver disease (NAFLD) is frequently found in humans. Deeme...
Non-alcoholic steatohepatitis (NASH) is a major cause of chronic liver disease. However, most availa...
Abstract: Research in nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatit...
Research in nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH),...
Aim: The aims of this study are to establish NASH animal model utilizing 1% and 12% cholesterol diet...
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, which occurs in the ...
In 1980, Ludwig and colleagues described a series of patients with liver histology characterized by ...
BACKGROUND: Animal models are an essential tool in non-alcoholic steatohepatitis (NASH) studies. Id...
International audienceNonalcoholic fatty liver disease (NAFLD) is the most common chronic liver dise...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Nonalcoholic steatohepatitis (NASH) arises from a variable interplay between environmental factors a...
A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing th...
Non-alcoholic steatohepatitis (NASH) develops from non-alcoholic fatty liver disease (NAFLD). Curren...
Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver d...
Research in nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH),...
A condition defined as nonalcoholic fatty liver disease (NAFLD) is frequently found in humans. Deeme...
Non-alcoholic steatohepatitis (NASH) is a major cause of chronic liver disease. However, most availa...
Abstract: Research in nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatit...
Research in nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH),...